<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Fatigue in myasthenia gravis: risk factors and impact on quality of life</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><forename type="first">Sarah</forename><surname>Hoffmann</surname></persName>
							<email>sarah.hoffmann@charite.de</email>
							<affiliation key="aff0">
								<orgName type="institution" key="instit1">NeuroCure Clinical Research Center</orgName>
								<orgName type="institution" key="instit2">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Department of Neurology</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Johanna</forename><surname>Ramm</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution" key="instit1">NeuroCure Clinical Research Center</orgName>
								<orgName type="institution" key="instit2">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">|</forename><forename type="middle">Ulrike</forename><surname>Grittner</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Center for Stroke Research (CSB)</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Department for Biostatistics and Clinical Epidemiology</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Siegfried</forename><surname>Kohler</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution" key="instit1">NeuroCure Clinical Research Center</orgName>
								<orgName type="institution" key="instit2">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Department of Neurology</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jana</forename><surname>Siedler</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution" key="instit1">NeuroCure Clinical Research Center</orgName>
								<orgName type="institution" key="instit2">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Andreas</forename><surname>Meisel</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution" key="instit1">NeuroCure Clinical Research Center</orgName>
								<orgName type="institution" key="instit2">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Department of Neurology</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff4">
								<orgName type="institution">Charite -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Fatigue in myasthenia gravis: risk factors and impact on quality of life</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">FCD62A4D38C463B980BA36A71588C54F</idno>
					<idno type="DOI">10.1002/brb3.538</idno>
					<note type="submission">Received: 10 January 2016 | Revised: 8 June 2016 | Accepted: 27 June 2016</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:42+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>activities of daily living</term>
					<term>cohort studies</term>
					<term>depression</term>
					<term>fatigue</term>
					<term>myasthenia gravis</term>
					<term>quality of life</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Objectives: Emerging evidence suggests that fatigue in myasthenia gravis (MG) is a relevant problem that negatively impacts activities of daily living (ADL).</s><s>The relationship between fatigue and quality of life (QoL) has never been systematically explored in MG patients.</s><s>The study aimed to assess the prevalence of fatigue and its relation to ADL and QoL as well as to identify factors associated with fatigue in MG.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Material and Methods</head><p><s>: This was a cross-sectional observational study in patients with confirmed diagnosis of MG independent of disease severity.</s><s>Prevalence of fatigue was assessed using the Chalder Fatigue Scale (CFQ).</s><s>Impact of fatigue on ADL and QoL was assessed by the MG activities of daily living profile (MG-ADL) and the MG-specific quality-of-life instrument (MG-QoL), respectively.</s><s>Association of fatigue with sociodemographics, clinical characteristics of MG, and comorbidities including mood and anxiety disorders as well as sleep disorders was investigated using multivariable logistic regression analyses.</s><s>Results: Overall, 200 MG patients were included.</s><s>The observed rate of fatigue was 56.1%, of those 70.4% fulfilled the criteria of chronic fatigue (CF) with a duration of ≥6 months.</s><s>Relevant fatigue was strongly associated to ADL and QoL.</s><s>Factors associated with relevant fatigue were disease severity and depressive state.</s><s>Furthermore, positive muscle-specific tyrosine kinase (MuSK) antibody status showed a strong association with relevant fatigue.</s><s>Conclusions: MG patients have a high prevalence of fatigue which negatively impacts ADL and QoL.</s><s>MG-specific clinical characteristics are related to fatigue and might help to identify MG patients at risk for fatigue.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>prevalence rates between 75% and 89% in MG patients <ref type="bibr" target="#b20">(Kluger, Krupp, &amp; Enoka, 2013)</ref> and qualitative data suggest that, in some patients, fatigue has a greater impact on daily living of MG patients than has muscle weakness <ref type="bibr" target="#b1">(Barnett, Bril, Kapral, Kulkarni, &amp; Davis, 2014;</ref><ref type="bibr" target="#b37">Zwarts, Bleijenberg, &amp; van Engelen, 2008)</ref>.</s><s>However, overall literature on fatigue in MG is scarce and its impact on activities of daily living (ADL) and quality of life (QoL) has never been systematically explored.</s><s>This might be due to various reasons.</s><s>Fatigue is a complex, nonspecific, and highly subjective symptom and therefore difficult to evaluate and quantify <ref type="bibr" target="#b23">(Krupp, LaRocca, Muir-Nash, &amp; Steinberg, 1989;</ref><ref type="bibr" target="#b29">Norheim, Jonsson, &amp; Omdal, 2011)</ref>.</s><s>The fluctuating and effortdependent nature of fatigue makes it even more difficult to separate fatigue from muscle fatigability in MG.</s><s>We follow recent proposals to use the term fatigue to refer to subjective sensations of exhaustion and muscle fatigability to refer to objective changes in muscle performance <ref type="bibr" target="#b20">(Kluger et al., 2013)</ref>.</s><s>Other related phenomena such as depression and sleep disorders need to be distinguished from fatigue and should therefore be included as covariates when assessing fatigue <ref type="bibr" target="#b20">(Kluger et al., 2013)</ref>.</s><s>Finally, the understanding of the pathophysiology of fatigue is limited.</s><s>MG is an autoimmune-mediated disease with autoantibodies directed against components of the postsynaptic muscular endplate <ref type="bibr" target="#b32">(Szczudlik et al., 2014)</ref>.</s><s>The most likely confinement to the peripheral nervous system makes hypotheses on the pathophysiology of fatigue in MG particularly challenging.</s></p><p><s>The aim of the present study was to assess the prevalence of fatigue and its impact on ADL and QoL in a large cohort of MG patients as well as to identify factors associated with fatigue including MGspecific clinical characteristics as well as potential confounders such as mood and sleep disturbances <ref type="bibr" target="#b10">(Elsais et al., 2013;</ref><ref type="bibr" target="#b20">Kluger et al., 2013)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2">| MATERIAL AND METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.1">| Patients</head><p><s>This was a cross-sectional, observational study performed at the certified Integrated Center for Myasthenia gravis (IMZ) of the Charité -Universitätsmedizin Berlin, Germany.</s><s>Patients over the age of 18 years with confirmed diagnosis of myasthenia gravis were included independent of disease duration and severity (excluding myasthenic crisis).</s><s>Patients were consecutively screened at the IMZ clinic between December 2012 and December 2013.</s></p><p><s>Sociodemographics (age, sex), current MG-specific medication (cholinesterase inhibitors, glucocorticoids, and long-term immunosuppressants), current comedication (antidepressants, NSAIDs, and opioids), and comorbidities (other immunopathies, cardiac insufficiency, and malignancies) were collected in a database.</s><s>Clinical assessment was performed using the MGFA classification for disease classification <ref type="bibr" target="#b19">(Jaretzki et al., 2000)</ref> and the QMG score for disease severity.</s><s>Using the MGFA classification, patients were grouped into ocular (MGFA I) or generalized MG patients (MGFA II-IV) at the time of study inclusion.</s><s>According to current recommendations, we used the MGFA classification by employing the most severely affected muscles to define the patient's MGFA class (the "maximum severity" designation being made historically; <ref type="bibr" target="#b19">Jaretzki et al., 2000)</ref>.</s><s>Thereby, patients were only assigned to MGFA I if symptomatology was restricted to purely ocular symptoms throughout the patient's entire disease history (ocular MG).</s></p><p><s>Correspondingly, patients with generalized symptoms (affecting limb/ axial and/or bulbar/respiratory muscles) throughout their disease history were assigned to generalized MG.</s><s>An exception to this approach was made in patients without any detectable myasthenic weakness under current medication who were assigned to "pharmacological remission."</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2">| Questionnaires</head><p><s>All patients completed the self-assessment questionnaires at the IMZ.</s><s>Completion of questionnaires required approximately 30 min.</s></p><p><s>If available, validated German versions of questionnaires were used, as in the case of the Chalder Fatigue Scale (CFQ; <ref type="bibr" target="#b25">Martin, Gaab, Rief, &amp; Brähler, 2010)</ref> and the Hospital Anxiety and Depression Scale (HADS; <ref type="bibr" target="#b17">Hinz &amp; Schwarz, 2001)</ref>.</s><s>The other questionnaires (Insomnia Severity Index, MG activities of daily living profile, and MG-specific quality-of-life instrument) were translated using forward-backward translation procedure by two physicians (SH, JR) who are both native German with excellent knowledge of English.</s><s>The translations were reviewed by the principal investigator (AM).</s><s>In case of discrepancies, a reconciled version was produced by a consensus conference.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2.1">| Chalder Fatigue Scale</head><p><s>For assessing fatigue, the CFQ presented by <ref type="bibr" target="#b8">Chalder et al. (1993)</ref> was used.</s><s>The CFQ is a self-administered questionnaire for measuring the severity of physical (CFQ-P) and mental (CFQ-M) fatigue within both clinical and epidemiological populations <ref type="bibr" target="#b18">(Jackson, 2015)</ref>.</s></p><p><s>It consists of 11 items that are answered on a 4-point scale ranging from the asymptomatic to maximum symptomatology, such as "less than usual," "no more than usual," "more than usual," and "much more than usual" offering the option of binary scoring (0 0 1 1) or Likert scoring (0 1 2 3).</s><s>We used the binary scoring (total score 0-11) to define caseness in patients with a score of 4 points or higher as proposed by  to evaluate mean fatigue scores in the different fatigue domains.</s><s>To differentiate between transient and chronic fatigue (CF), we assessed fatigue duration by asking if symptoms were present for &lt;6 months or longer.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2.2">| MG-specific quality-of-life instrument</head><p><s>MG-specific quality-of-life instrument (MG-QoL) is a 15-item questionnaire encompassing physical and psychological domains of MG to assess disease-specific QoL in MG patients <ref type="bibr" target="#b5">(Burns, Conaway, Cutter, &amp; Sanders, 2008)</ref>.</s><s>Rating consists of a 5-point scale ranging from 0 ("not at all") to 4 ("very much") as to the degree to which patients agree with the given statement summing up to a total score of 0-60 points.</s></p><p><s>| e00538 (3 of 8)</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2.3">| MG activities of daily living profile</head><p><s>Impact on daily living was assessed using the MG activities of daily living profile (MG-ADL; <ref type="bibr" target="#b35">Wolfe et al., 1999)</ref>.</s><s>It is an eight-question survey of symptom severity, with each response graded from 0 (normal) to 3 (most severe).</s><s>Questions include ocular, oropharyngeal, respiratory, and extremity functions.</s><s>Total MG-ADL score ranges from 0 to 24.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2.4">| Hospital anxiety and depression scale</head><p><s>Hospital anxiety and depression scale is a self-assessment mood scale developed to identify cases of anxiety disorders and depression among patients in nonpsychiatric hospital clinics <ref type="bibr" target="#b36">(Zigmond &amp; Snaith, 1983)</ref>.</s><s>It is divided into an anxiety subscale (HADS-A) and a depression subscale (HADS-D) both containing seven items <ref type="bibr" target="#b3">(Bjelland, Dahl, Haug, &amp; Neckelmann, 2002)</ref> with a 0-to 3-point Likert response format summing up to a total score of 21 for each subscale.</s><s>A cut-off score of 8 or higher on each subscale was used to define caseness of anxiety and depression, respectively <ref type="bibr" target="#b3">(Bjelland et al., 2002)</ref>.</s><s>Symptoms of mood disorders likely to be present in somatic disorders (e.g., insomnia, fatigue, anorexia) are excluded in the HADS.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2.5">| Insomnia Severity Index</head><p><s>Sleep disturbances were assessed using the ISI.</s><s>It is a seven-item selfreport instrument targeting the subjective symptoms and consequences of insomnia <ref type="bibr" target="#b2">(Bastien, Vallieres, &amp; Morin, 2001)</ref>.</s><s>Using the Likert scale, each item is rated between 0 to 4 points summing up to a total score range from 0 to 28.</s><s>We used a cut-off score of 10 points to define caseness of sleep disturbances <ref type="bibr" target="#b27">(Morin, Belleville, Belanger, &amp; Ivers, 2011)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.3">| Statistical analysis</head><p><s>Descriptive analyses included reports of means and standard deviation, median and interquartile range (IQR), or absolute and relative frequencies depending on the scale and distribution of variables.</s><s>We compared sociodemographic characteristics, questionnaire scores, and clinical characteristics between the myasthenia subgroups using Fisher's exact test, chi-square test, one-way ANOVA, or Kruskal-Wallis test where indicated (Tables <ref type="table" target="#tab_2">1 and 2</ref>).</s><s>To analyze association of characteristics with clinical-relevant fatigue, we used t-test, Mann-Whitney test, Fisher's exact test, or chi-square test (Table <ref type="table">3</ref>).</s><s>In multiple logistic regression analysis we included and tested variables that were associated with relevant fatigue in univariate analysis (p &lt; .05).</s></p><p><s>As all six MuSK-ab-positive patients had relevant fatigue, the problem of quasi-separation appears resulting in nonexistence of OR and CI estimates.</s><s>Therefore, Firth logistic regression was used (Stata/IC 13.1 command firthlogit), estimating ORs and CIs with penalized likelihood estimation methods <ref type="bibr" target="#b15">(Heinze &amp; Schemper, 2002)</ref>.</s><s>Only significant variables remained in the final model with the exception of MuSK-ab which was forced into the model.</s><s>We used a two-sided significance level of alpha = 0.05.</s><s>Linear regression was used to analyze association of relevant fatigue with ADL and QoL adjusted for MG type (one regression model for each outcome, Fig. <ref type="figure">1</ref>).</s><s>No adjustment for multiple testing was applied as this is an exploratory study.</s><s>Statistical tests were performed using SPSS 22 (IBM, Armonk, NY, USA).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>T A B L E 1 Baseline characteristics</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.4">| Ethics</head><p><s>The study was approved by the ethics committee of the Charité -Universitätsmedizin Berlin (EA1/281/10).</s><s>All patients gave written informed consent in accordance with the Declaration of Helsinki in its currently applicable form.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3">| RESULTS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.1">| Patient's demographic and clinical characteristics</head><p><s>Overall</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.2">| Fatigue prevalence and severity</head><p><s>Relevant fatigue (CFQ ≥ 4 points on the binary scale) was present in 110 (56.1%) of MG patients (</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.3">| Prevalence of mood, anxiety, and sleep disorders</head><p><s>Using a cut-off score of ≥8 points on the HADS, rates for depression and anxiety in the total sample are 19.6% and 27.8%, respectively (Table <ref type="table" target="#tab_2">2</ref>).</s><s>Rate of sleeping disturbances defined as a cut-off score of ≥10 points on the ISI were 41.5%.</s><s>Both, mood and sleeping disorders were more frequent in patients with GMG compared to those with OMG or in pharmacological remission.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.4">| Factors associated with relevant fatigue: univariate and multivariate analysis</head><p><s>The following characteristics were associated with relevant fatigue in univariate analysis (Table <ref type="table">3</ref>): female sex, GMG, positive AchR or MuSK antibody status, medication with cholinesterase inhibitors or opioids, thymectomy, presence of other immunopathies, higher QMG score, higher HADS-D and HADS-A scores, and higher ISI score.</s></p><p><s>Multivariable logistic regression showed that higher QMG score and higher HADS-D score were significantly associated with relevant fatigue after adjustment for each other and for positive MuSK-ab status (Table <ref type="table">4</ref>).</s><s>Positive MuSK-ab status showed a strong association with relevant fatigue, although due to the low case number this finding did not reach statistical significance.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.5">| Fatigue and its association with quality of life and activities of daily living</head><p><s>Figure <ref type="figure">1</ref> shows that quality of life as measured by the MG-QoL15</s></p><p><s>and activities of daily living as measured by the MG-ADL scores were</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4">| DISCUSSION</head><p><s>Our study adds to the scarce literature on fatigue in MG by demonstrating a high prevalence of fatigue among MG patients and showing a negative impact of fatigue on QoL in MG patients.</s><s>Furthermore, we identified disease severity and depressive state as independent risk factors associated with fatigue in MG patients.</s></p><p><s>The prevalence of fatigue in our MG cohort was 56.1%.</s><s>A recent study by <ref type="bibr" target="#b10">Elsais et al. (2013)</ref> using the same questionnaire in a</s></p><p><s>Norwegian MG population reported a fatigue rate of 44%.</s><s>The higher fatigue rate in our cohort might be explained by a higher disease severity.</s><s><ref type="bibr" target="#b10">Elsais et al. (2013)</ref> only included patients with MGFA grade II or better, whereas we only excluded patients with myasthenic crisis.</s></p><p><s>Consistently, a higher QMG score was associated with a higher prev-  We included measures of mood and sleep disturbances as covariates in our analyses as recommended by other research groups <ref type="bibr" target="#b10">(Elsais et al., 2013;</ref><ref type="bibr" target="#b20">Kluger et al., 2013)</ref>.</s><s>Depressive state was associated with higher prevalence of fatigue.</s><s>The association between fatigue and depression is widely accepted and mainly attributed to the overlap in symptomatology between fatigue and depression (such as physical fatigue; <ref type="bibr" target="#b29">Norheim et al., 2011)</ref>.</s><s>Rate of depressive state was 19.6% in our MG cohort and thereby comparable to those in the general German population <ref type="bibr" target="#b16">(Hinz &amp; Brahler, 2011)</ref>.</s><s>It has long been suggested that depression is common among MG patients <ref type="bibr" target="#b7">(Chafetz, 1966;</ref><ref type="bibr" target="#b26">Meyer, 1966)</ref>.</s><s>However, more recent studies show inconsistent results.</s><s>Although some studies report markedly higher depression rates of up to 33% in MG patients <ref type="bibr" target="#b11">(Fisher, Parkinson, &amp; Kothari, 2003;</ref><ref type="bibr" target="#b24">Magni et al., 1988)</ref>, others have found no increased frequency of depression in MG patients over the general population <ref type="bibr" target="#b9">(Doering, Henze, &amp; Schussler, 1993;</ref><ref type="bibr" target="#b34">Tennant, Wilby, &amp; Nicholson, 1986)</ref>.</s><s>These conflicting results might be partially attributable to the use of different measures of depression across the studies.</s></p><p><s>The use of the HADS which was developed to identify caseness of anxiety disorders and depression among patients in nonpsychiatric hospital clinics and therefore excludes physical symptoms might be particularly suitable to overcome the overlap in symptomatology between MG, fatigue, depression, and sleep disorders.</s></p><p><s>Positive MuSK antibody status shows a strong influence on relevant fatigue, although this finding did not reach statistical significance.</s><s>This might be due to the low case number (n = 6).</s><s>However, the prevalence of MuSK-positive patients among AchR-negative patients was 17.6% and thereby comparable to the prevalence of other European MG cohorts <ref type="bibr" target="#b21">(Kostera-Pruszczyk et al., 2008;</ref><ref type="bibr" target="#b28">Niks, Kuks, &amp; Verschuuren, 2007)</ref>.</s><s>Attempts have been made to better characterize MG patients by their antibody status and differences were found for patterns of involved muscles, disease severity, as well as treatment responses <ref type="bibr" target="#b30">(Ohta et al., 2007)</ref>.</s><s>Interestingly, all of the MuSK-positive MG patients reported relevant fatigue.</s><s>Due to the low case number, this finding needs to be interpreted with caution but MuSK-ab and their association with relevant fatigue seem to be a promising target for further investigations.</s><s>Future studies on fatigue in MG should furthermore consider newly described antibodies such as anti-LRP4 and anti-Agrin antibodies <ref type="bibr">(Gasperi et al., 2014)</ref>.</s></p><p><s>Our study has several limitations that need to be acknowledged.</s></p><p><s>The study design did not include a healthy control group to compare our data with.</s><s>However, the herein used CFS allows for comparisons of fatigue prevalence in the general population <ref type="bibr" target="#b25">(Martin et al., 2010)</ref> and other MG cohorts <ref type="bibr" target="#b10">(Elsais et al., 2013)</ref>.</s><s>Main objectives of our study were furthermore the identification of clinical factors associated with fatigue in MG assessing QoL and ADL with MGspecific self-questionnaires which could not have been performed in a group of healthy controls.</s><s>Patients were grouped into OMG and GMG patients by employing the most severely affected muscles to define the patient's MGFA class.</s><s>This might have introduced a bias as GMG patients could have presented with purely ocular symptoms at study inclusion.</s><s>However, in our experience, a mild affection of other than purely ocular muscles is noticeable for most GMG patients.</s><s>For some of the questionnaires used in this study (ISI, MG-ADL, MG-QoL), validated German versions were not available which might have influenced the results.</s><s>Statistical analysis did not include multiple testing.</s><s>However, this was an exploratory analysis without any predefined hypotheses and predictors for relevant fatigue were identified using multivariable regression analysis.</s><s>Further limitations include potential shortcomings concerning the clinical factors included in our analyses.</s><s>For example, comedication did not consider hypnotics and betablockers despite their reported negative effect on fatigue <ref type="bibr" target="#b4">(Braley, Segal, &amp; Chervin, 2015;</ref><ref type="bibr" target="#b33">Tang, Yu, &amp; Yeh, 2010)</ref>.</s></p><p><s>The test battery with five self-assessment questionnaires might have influenced the results.</s><s>Patients were free to decide on the order of questionnaire completion, therefore, we cannot entirely exclude an overestimation of mental fatigue due to prior concentration on completion of other questionnaires.</s><s>However, increasing emphasis has been placed on self-reporting instruments as they allow for an assessment of highly subjective conditions such as fatigue as well as for an evaluation of the impact of diseases such as QoL and ADL <ref type="bibr" target="#b35">(Wolfe et al., 1999)</ref>.</s></p><p><s>In conclusion, our study emphasizes the importance of fatigue in MG even in patients in pharmacological remission and its impact on ADL and QoL.</s><s>MG-specific clinical characteristics seem to have</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head></head><label></label><figDesc><div><p><s>alence of relevant fatigue.</s><s>It is noteworthy, that the QMG score is an instrument to measure muscle fatigability, not fatigue.</s><s>The authors are aware of the challenge of separating fatigue from muscle fatigability.</s><s>Fatigue is a multidimensional concept covering both physical and psychological aspects making it difficult to assess fatigue in neurological diseases in general and in MG in particular.</s><s>However, the high prevalence of fatigue in our cohort and its negative impact on ADL and QoL underline the need of further research on fatigue in MG.Moreover, one third of MG patients in pharmacological remission in our cohort suffered from relevant fatigue.</s><s>Our finding is consistent with the results of<ref type="bibr" target="#b10">Elsais et al. (2013)</ref> suggesting that factors other than myasthenic muscle weakness are involved in the pathogenesis of fatigue in MG.</s><s>Furthermore, the distinction between fatigue and muscle fatigability might be of practical relevance, for example, might</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 2</head><label>2</label><figDesc></figDesc><table /><note><p><s>).Rates of relevant fatigue ranged from 31.7% in patients in pharmacological remission to 71.6% in patients with generalized MG (p &lt; .001).GMG patients had significantly higher CFQ scores (Likert scale) in the physical as well as in the mental domain compared to remitted MG as well as OMG patients (Table2).</s><s>Within the group of patients with relevant fatigue, chronic fatigue (≥6 months) was similarly distributed among patients with GMG (72.0%) compared to patients with OMG (64.3%) or patients in pharmacological remission (66.7%).</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head></head><label></label><figDesc><div><p><s>T A B L E 2 Prevalence and severity of relevant fatigue, prevalence of mood, anxiety, and sleep disorders</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell cols="4">significantly higher (higher scores indicating more severe symptoms) in</cell></row><row><cell>Parameter</cell><cell>All</cell><cell cols="4">GMG patients with relevant fatigue (p &lt; .001). Within the group of patients OMG Remission p-value with relevant fatigue, mean MG-QoL score was 22.7 points in GMG</cell></row><row><cell>n</cell><cell>196</cell><cell cols="4">116 patients compared to patients with OMG (19.3) and patients in phar-39 41</cell></row><row><cell>CFQ ≥ 4 items, n (%)</cell><cell>110 (56.1)</cell><cell cols="4">83 (71.6) macological remission (8.6). Mean MG-ADL score within the group of 14 (35.9) 13 (31.7) &lt;.001</cell></row><row><cell>CFQ-T score, mean (SD)</cell><cell>15.6 (6.2)</cell><cell cols="4">17.5 (6.0) patients with relevant fatigue was 6.2 points in GMG patients com-14.0 (5.6) 11.7 (5.0) &lt;.001</cell></row><row><cell>CFQ-P score, mean (SD)</cell><cell>10.7 (4.5)</cell><cell cols="4">12.1 (4.3) pared to patients with OMG (4.8 points) and patients in pharmacologi-9.4 (4.1) 7.8 (3.7) &lt;.001</cell></row><row><cell>CFQ-M score, mean (SD)</cell><cell>4.9 (2.3)</cell><cell cols="2">5.4 (2.4) cal remission (3.3 points). 4.7 (2.2)</cell><cell>3.9 (1.9)</cell><cell>.002</cell></row><row><cell>CF ≥ 6 months within n = 108 patients with</cell><cell>76 (70.4)</cell><cell>59 (72.0)</cell><cell>9 (64.3)</cell><cell>8 (66.7)</cell><cell>.808</cell></row><row><cell>relevant fatigue, n (%) (2 missings)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>HADS-D ≥ 8 points, n (%) (6 missings)</cell><cell>38 (19.6)</cell><cell>28 (24.6)</cell><cell>6 (15.4)</cell><cell>4 (9.8)</cell><cell>.093</cell></row><row><cell>HADS-A ≥ 8 points, n (%) (6 missings)</cell><cell>54 (27.8)</cell><cell>41 (36.0)</cell><cell>7 (17.9)</cell><cell>6 (14.6)</cell><cell>.010</cell></row><row><cell>ISI ≥ 10 points, n (%)</cell><cell>83 (41.5)</cell><cell>61 (51.3)</cell><cell>12 (30.8)</cell><cell>10 (23,8)</cell><cell>.003</cell></row><row><cell cols="6">GMG, generalized myasthenia gravis; OMG, ocular myasthenia gravis; CFQ, Chalder Fatigue Scale; CFQ-T, CFQ-Total; CFQ-P, CFQ-Physical; CFQ-M,</cell></row><row><cell cols="6">CFQ-Mental; CF, chronic fatigue (≥6 months); ISI, Insomnia Severity Index; HADS, Hospital Anxiety and Depression Scale; HADS-D, HADS-Depression;</cell></row><row><cell cols="2">HADS-A, HADS-Anxiety; MG-ADL, MG activities of daily living profile.</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="4">p-values refer to overall group comparisons of patients with generalized MG, ocular MG, and pharmacological remission.</cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_5"><head></head><label></label><figDesc><div><p><s>T A B L E 4 Factors associated with clinically relevant fatigue: final multivariable analyses QMG, quantitative myasthenia gravis score; HADS-D, Hospital Anxiety and Depression Scale-Depression; MuSK, muscle-specific tyrosine kinase; CFQ, Chalder Fatigue Scale.Firth regression model (n = 173), odds ratios (OR), and 95% CI (Tjur's r 2 = .45)(MuSK-ab</s><s>was forced into the model, otherwise only significant coefficients remained in the final model).an</s><s>influence on fatigue and might help to identify MG patients at risk for fatigue.</s><s>Fatigue could be misinterpreted as muscle fatigability or mood disorders.</s><s>Therefore, depressive state should be assessed excluding physical symptoms of depression in order to avoid overestimation of depressive state in MG patients.</s><s>Future clinical trials in MG should include fatigue as endpoint in order to assess if fatigue changes with improvement of disease severity or whether fatigue in MG needs to be treated independently of muscle fatigability.</s></p></div></figDesc><table><row><cell></cell><cell>Relevant fatigue (CFQ ≥ 4)</cell></row><row><cell>Characteristic</cell><cell>OR (95% CI)</cell></row><row><cell>QMG score</cell><cell>1.17 (1.07-1.27)</cell></row><row><cell>HADS-D</cell><cell>1.55 (1.31-1.82)</cell></row><row><cell>MuSK</cell><cell>15.63 (0.67-362.46)</cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">e00538 (6 of 8) | Hoffmann et al.</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ACKNOWLEDGMENTS</head><p><s>None.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>FUNDING INFORMATION</head><p><s>This study was supported by the Deutsche Forschungsgemeinschaft (Grant/Award Number: Exc 257).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CONFLICTS OF INTEREST</head><p><s>This study was supported by the Deutsche Forschungsgemeinschaft (DFG Exc 257 to Andreas Meisel).</s><s>Andreas Meisel and Siegfried Kohler have received speaker's honoraria from Novartis and Biomarin and a research grant from Novartis.</s><s>Sarah Hoffmann, Johanna, Ramm, Ulrike Grittner, and Jana Siedler report no disclosures.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Vitamin D deficiency in patients with myasthenia gravis and improvement of fatigue after supplementation of vitamin D3: A pilot study</title>
		<author>
			<persName><forename type="first">H</forename><surname>Askmark</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Haggard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Nygren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Punga</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">European Journal of Neurology</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="1554" to="1560" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">A conceptual framework for evaluating impairments in myasthenia gravis</title>
		<author>
			<persName><forename type="first">C</forename><surname>Barnett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Bril</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kapral</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kulkarni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Davis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">e98089</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Validation of the Insomnia Severity Index as an outcome measure for insomnia research</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Bastien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Vallieres</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Morin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sleep Medicine</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="297" to="307" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">The validity of the Hospital Anxiety and Depression Scale. An updated literature review</title>
		<author>
			<persName><forename type="first">I</forename><surname>Bjelland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Dahl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">T</forename><surname>Haug</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Neckelmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Psychosomatic Research</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="69" to="77" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Hypnotic use and fatigue in multiple sclerosis</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Braley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Segal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Chervin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sleep Medicine</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="131" to="137" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<monogr>
		<title level="m" type="main">Less is more, or almost as much: A 15-item quality-of-life instrument for myasthenia gravis. Muscle and Nerve</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Burns</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Conaway</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Cutter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Sanders</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2008">2008</date>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="957" to="963" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Muscle strength in myasthenia gravis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Cejvanovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Vissing</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Neurologica Scandinavica</title>
		<imprint>
			<biblScope unit="volume">129</biblScope>
			<biblScope unit="page" from="367" to="373" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<monogr>
		<title level="m" type="main">Psychological disturbances in myasthenia gravis. Annals of the</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Chafetz</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1966">1966</date>
			<publisher>New York Academy of Sciences</publisher>
			<biblScope unit="volume">135</biblScope>
			<biblScope unit="page" from="424" to="427" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Development of a fatigue scale</title>
		<author>
			<persName><forename type="first">T</forename><surname>Chalder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Berelowitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Pawlikowska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Watts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wessely</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Wright</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">P</forename><surname>Wallace</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Psychosomatic Research</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="147" to="153" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Coping with myasthenia gravis and implications for psychotherapy</title>
		<author>
			<persName><forename type="first">S</forename><surname>Doering</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Henze</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Schussler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Archives of Neurology</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="page" from="617" to="620" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Fatigue in myasthenia gravis: Is it more than muscular weakness?</title>
		<author>
			<persName><forename type="first">A</forename><surname>Elsais</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">B</forename><surname>Wyller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Loge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Kerty</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Neurology</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page">132</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Self-reported depressive symptoms in Myasthenia Gravis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Fisher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Parkinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Kothari</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Clinical Neuromuscular Disease</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="105" to="108" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">C</forename><surname>Gasperi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Melms</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Schoser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Meltoranta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Risson</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Anti-agrin autoantibodies in myasthenia gravis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Kroger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<biblScope unit="page" from="1976" to="1983" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<monogr>
		<title level="m" type="main">Lifetime course of myasthenia gravis. Muscle and Nerve</title>
		<author>
			<persName><forename type="first">D</forename><surname>Grob</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Brunner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Namba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pagala</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2008">2008</date>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="141" to="149" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">A solution to the problem of separation in logistic regression</title>
		<author>
			<persName><forename type="first">G</forename><surname>Heinze</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schemper</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Statistics in Medicine</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="2409" to="2419" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Normative values for the hospital anxiety and depression scale (HADS) in the general German population</title>
		<author>
			<persName><forename type="first">A</forename><surname>Hinz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Brahler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Psychosomatic Research</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="page" from="74" to="78" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Anxiety and depression in the general population: Normal values in the Hospital Anxiety and Depression Scale</title>
		<author>
			<persName><forename type="first">A</forename><surname>Hinz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Schwarz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychotherapie, Psychosomatik, medizinische Psychologie</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="193" to="200" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
	<note>Angst und Depression in der Allgemeinbevolkerung. Eine Normierungsstudie zur Hospital Anxiety and Depression Scale</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">The Chalder Fatigue Scale (CFQ 11)</title>
		<author>
			<persName><forename type="first">C</forename><surname>Jackson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Occupational Medicine</title>
		<imprint>
			<biblScope unit="page">86</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Myasthenia gravis: Recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America</title>
		<author>
			<persName><forename type="first">A</forename><surname>Jaretzki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Barohn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Ernstoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Kaminski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Keesey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Penn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Sanders</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="16" to="23" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Fatigue and fatigability in neurologic illnesses: Proposal for a unified taxonomy</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Kluger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">B</forename><surname>Krupp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Enoka</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">80</biblScope>
			<biblScope unit="page" from="409" to="416" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">A</forename><surname>Kostera-Pruszczyk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kaminska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Dutkiewicz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Emeryk-Szajewska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Strugalska-Cynowska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Vincent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kwiecinski</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">MuSK-positive myasthenia gravis is rare in the Polish population</title>
	</analytic>
	<monogr>
		<title level="j">European Journal of Neurology</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="720" to="724" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">B</forename><surname>Krupp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">G</forename><surname>Larocca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Muir-Nash</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Steinberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Archives of Neurology</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="1121" to="1123" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Psychiatric disturbances associated with myasthenia gravis</title>
		<author>
			<persName><forename type="first">G</forename><surname>Magni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">F</forename><surname>Micaglio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Lalli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bejato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Candeago</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Merskey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Angelini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Psychiatrica Scandinavica</title>
		<imprint>
			<biblScope unit="volume">77</biblScope>
			<biblScope unit="page" from="443" to="445" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<monogr>
		<title level="m" type="main">Messung chronischer Erschöpfung -Teststatistische Prüfung der Fatigue Skala (FS)</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">T S</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gaab</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Rief</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Brähler</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2010">2010</date>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="33" to="44" />
		</imprint>
		<respStmt>
			<orgName>Zeitschrift für Klinische Psychologie und Psychotherapie</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Psychological disturbances in myasthenia gravis: A predictive study</title>
		<author>
			<persName><forename type="first">E</forename><surname>Meyer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Annals of the New York Academy of Sciences</title>
		<imprint>
			<biblScope unit="volume">135</biblScope>
			<biblScope unit="page" from="417" to="423" />
			<date type="published" when="1966">1966</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">The Insomnia Severity Index: Psychometric indicators to detect insomnia cases and evaluate treatment response</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Morin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Belleville</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Belanger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ivers</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sleep</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="601" to="608" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Epidemiology of myasthenia gravis with anti-muscle specific kinase antibodies in The Netherlands</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">H</forename><surname>Niks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Kuks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Verschuuren</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurosurgery, and Psychiatry</title>
		<imprint>
			<biblScope unit="volume">78</biblScope>
			<biblScope unit="page" from="417" to="418" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note>Journal of Neurology</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Biological mechanisms of chronic fatigue</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">B</forename><surname>Norheim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Jonsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Omdal</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Rheumatology (Oxford)</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="page" from="1009" to="1018" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Clinical and experimental features of MuSK antibody positive MG in Japan</title>
		<author>
			<persName><forename type="first">K</forename><surname>Ohta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Shigemoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fujinami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Maruyama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Konishi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ohta</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">European Journal of Neurology</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="1029" to="1034" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Fatigue and its impact on patients with myasthenia gravis</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Paul</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Cohen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Goldstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Gilchrist</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Muscle and Nerve</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="1402" to="1406" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Antititin antibody in early-and late-onset myasthenia gravis</title>
		<author>
			<persName><forename type="first">P</forename><surname>Szczudlik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Szyluk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lipowska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Ryniewicz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kubiszewska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Dutkiewicz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">.</forename><forename type="middle">.</forename><surname>Kostera-Pruszczyk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Neurologica Scandinavica</title>
		<imprint>
			<biblScope unit="volume">130</biblScope>
			<biblScope unit="page" from="229" to="233" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Fatigue and its related factors in patients with chronic heart failure</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">R</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Y</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Yeh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Clinical Nursing</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="69" to="78" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Psychological correlates of myasthenia gravis: A brief report</title>
		<author>
			<persName><forename type="first">C</forename><surname>Tennant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wilby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Nicholson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Psychosomatic Research</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="575" to="580" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Myasthenia gravis activities of daily living profile</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">I</forename><surname>Wolfe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Herbelin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Nations</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Foster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">W</forename><surname>Bryan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Barohn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="1487" to="1489" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">The hospital anxiety and depression scale</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Zigmond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Snaith</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Psychiatrica Scandinavica</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="page" from="361" to="370" />
			<date type="published" when="1983">1983</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Clinical neurophysiology of fatigue</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Zwarts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Bleijenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">G</forename><surname>Van Engelen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clinical Neurophysiology</title>
		<imprint>
			<biblScope unit="volume">119</biblScope>
			<biblScope unit="page" from="2" to="10" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Fatigue in myasthenia gravis: risk factors and impact on quality of life</title>
		<author>
			<persName><forename type="first">S</forename><surname>Hoffmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ramm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Grittner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kohler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Siedler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Meisel</surname></persName>
		</author>
		<idno type="DOI">10.1002/brb3.538</idno>
	</analytic>
	<monogr>
		<title level="j">Brain and Behavior</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="1" to="8" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
